Literature DB >> 25207188

Contribution of diffusion-weighted imaging to diagnosis and staging of cervical cancer.

Tuna Demirbaş1, Tan Cimilli2, Sibel Bayramoğlu2, Nurten Turan Güner2, Elif Hocaoğlu2, Ercan Inci2.   

Abstract

BACKGROUND: Cervical cancer is the second most common female malignancy worldwide. Although its incidence has decreased in developed countries due to screening with Papanicolaou test, it is still the leading cause of cancer-related female death in developing countries. AIMS: The aim of this study was to determine whether the apparent diffusion coefficient (ADC) measurements calculated from diffusion-weighted imaging (DWI) images had any contribution in differentiation of normal cervical tissue from malignant lesions preoperatively, and whether there was a correlation between the mean ADC values and tumor type, grade, or stage in malignant lesions. STUDY
DESIGN: Case-control study.
METHODS: Mean ADC values in 25 patients who had cervical cancer proved histopathologically, and 20 patients with otherwise normal uterus were compared. Also in the study group, mean ADC values were compared between histopathologic subtypes, tumor grades, and stages.
RESULTS: In the study group the mean ADC values (0.96±0.15×10(-3) mm(2)/s) were statistically lower than that of the control group (1.67±0.17×10(-3) mm(2)/s) (p<0.05). According to histopathologic sub-types there was no significant difference between mean ADC values of squamous cell cancer and adenocarcinoma (0.95×10(-3) mm(2)/s and 0.91×10(-3) mm(2)/s, respectively) (p>0.05). There was also no significant difference between the mean ADC values of the tumor grades (p>0.05). The mean ADC values in early stage cervical cancer (0.86±0.05×10(-3) mm(2)/s) were significantly lower than the mean ADC values in late stage disease (0.98±0.06×10(-3) mm(2)/s) (p<0.05).
CONCLUSION: ADC value measurements may provide useful information in diagnosis of cervical cancer as well as in preoperative assessment of the tumor stage.

Entities:  

Keywords:  Apparent diffusion coefficient; cervical cancer; cervix; magnetic resonance

Year:  2014        PMID: 25207188      PMCID: PMC4115932          DOI: 10.5152/balkanmedj.2014.13122

Source DB:  PubMed          Journal:  Balkan Med J        ISSN: 2146-3123            Impact factor:   2.021


  20 in total

1.  [Diffusion weighted imaging features of normal uterine cervix and cervical carcinoma].

Authors:  Yun Zhang; Bi-Ling Liang; Li Gao; Rui-Xin Ye; Jun Shen; Jing-Lian Zhong
Journal:  Ai Zheng       Date:  2007-05

2.  Cervical cancer screening rates in the United States and the potential impact of implementation of screening guidelines.

Authors:  Diane Solomon; Nancy Breen; Timothy McNeel
Journal:  CA Cancer J Clin       Date:  2007 Mar-Apr       Impact factor: 508.702

3.  Revised FIGO staging for carcinoma of the cervix.

Authors:  Sergio Pecorelli; Lucia Zigliani; Franco Odicino
Journal:  Int J Gynaecol Obstet       Date:  2009-04-01       Impact factor: 3.561

4.  Human papillomavirus is a necessary cause of invasive cervical cancer worldwide.

Authors:  J M Walboomers; M V Jacobs; M M Manos; F X Bosch; J A Kummer; K V Shah; P J Snijders; J Peto; C J Meijer; N Muñoz
Journal:  J Pathol       Date:  1999-09       Impact factor: 7.996

Review 5.  Diffusion-weighted magnetic resonance imaging and its application to cancer.

Authors:  Elizabeth M Charles-Edwards; Nandita M deSouza
Journal:  Cancer Imaging       Date:  2006-09-13       Impact factor: 3.909

6.  Quantitative diffusion-weighted magnetic resonance imaging of normal and diseased uterine zones.

Authors:  O Kilickesmez; S Bayramoglu; E Inci; T Cimilli; A Kayhan
Journal:  Acta Radiol       Date:  2009-04       Impact factor: 1.990

7.  Diffusion-weighted magnetic resonance imaging of uterine cervical cancer.

Authors:  Ying Liu; Renju Bai; Haoran Sun; Haidong Liu; Dehua Wang
Journal:  J Comput Assist Tomogr       Date:  2009 Nov-Dec       Impact factor: 1.826

8.  Diffusion weighted whole body imaging with background body signal suppression (DWIBS): technical improvement using free breathing, STIR and high resolution 3D display.

Authors:  Taro Takahara; Yutaka Imai; Tomohiro Yamashita; Seiei Yasuda; Seiji Nasu; Marc Van Cauteren
Journal:  Radiat Med       Date:  2004 Jul-Aug

Review 9.  Imaging of cancer of the cervix.

Authors:  Juergen Scheidler; Andreas F Heuck
Journal:  Radiol Clin North Am       Date:  2002-05       Impact factor: 2.303

10.  Diffusion-weighted MRI in cervical cancer.

Authors:  Patrick Z McVeigh; Aejaz M Syed; Michael Milosevic; Anthony Fyles; Masoom A Haider
Journal:  Eur Radiol       Date:  2008-01-12       Impact factor: 5.315

View more
  6 in total

1.  Diffusion-weighted and diffusion-tensor imaging of normal and diseased uterus.

Authors:  Duygu Kara Bozkurt; Murat Bozkurt; Mehmet Ali Nazli; Ilhan Nahit Mutlu; Ozgur Kilickesmez
Journal:  World J Radiol       Date:  2015-07-28

2.  Contribution of mono-exponential, bi-exponential and stretched exponential model-based diffusion-weighted MR imaging in the diagnosis and differentiation of uterine cervical carcinoma.

Authors:  Meng Lin; Xiaoduo Yu; Yan Chen; Han Ouyang; Bing Wu; Dandan Zheng; Chunwu Zhou
Journal:  Eur Radiol       Date:  2016-09-27       Impact factor: 5.315

3.  Diagnostic Performance of Diffusion-Weighted Imaging for Colorectal Cancer Detection: An Updated Systematic Review and Meta-Analysis.

Authors:  Yunfei Xiao; Juan Li; Jiamei Zhong; Dequan Chen; Jianbo Shi; Hongrui Jin
Journal:  Front Oncol       Date:  2022-06-23       Impact factor: 5.738

4.  Magnetic resonance imaging of adenoma malignum of the uterine cervix with pathologic correlation: a case report.

Authors:  Alba Castán Senar; Blanca Paño; Adela Saco; Carlos Nicolau
Journal:  Radiol Case Rep       Date:  2016-09-20

5.  Role of apparent diffusion coefficient as a biomarker in the evaluation of cervical cancer.

Authors:  Sunita Dashottar; T Preeth Pany; Nishant Lohia
Journal:  Indian J Radiol Imaging       Date:  2019 Jan-Mar

6.  Value of diffusion-weighted imaging in preoperative evaluation and prediction of postoperative supplementary therapy for patients with cervical cancer.

Authors:  Liying Liu; Shuo Wang; Tao Yu; Haoyan Bai; Jingyu Liu; Danbo Wang; Yahong Luo
Journal:  Ann Transl Med       Date:  2022-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.